News

Deal Announcements

Proteon Therapeutics Lands $38 Million Venture Capital

Friday, March 6, 2009 5:35:00 AM PDT | VentureDeal Staff
Waltham, Massachusetts  --  Biotechnology company Proteon Therapeutics has raised $38 million in its series B round of venture capital financing.

Proteon is developing a human recombinant protein that it claims permanently dilates segments of blood vessels, blocks vasospasm and reduces the formation of vascular scarring.

MPM Capital led the round, which included TVM Capital, Skyline Ventures, Prism VentureWorks and Intersouth Partners. The company did not disclose how it could use the investment proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1